| Cellular senescence: defining a path forward V Gorgoulis, PD Adams, A Alimonti, DC Bennett, O Bischof, C Bishop, ... Cell 179 (4), 813-827, 2019 | 2352 | 2019 |
| Chronic p53-independent p21 expression causes genomic instability by deregulating replication licensing P Galanos, K Vougas, D Walter, A Polyzos, A Maya-Mendoza, ... Nature cell biology 18 (7), 777-789, 2016 | 318 | 2016 |
| A deep learning framework for predicting response to therapy in cancer T Sakellaropoulos, K Vougas, S Narang, F Koinis, A Kotsinas, A Polyzos, ... Cell reports 29 (11), 3367-3373. e4, 2019 | 203 | 2019 |
| Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis L Kolilekas, E Manali, KA Vlami, P Lyberopoulos, C Triantafillidou, ... Journal of Clinical Sleep Medicine 9 (6), 593-601, 2013 | 161 | 2013 |
| Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of … E Gkogkou, G Barnasas, K Vougas, IP Trougakos Redox biology 36, 101615, 2020 | 158 | 2020 |
| The DNA damage response and immune signaling alliance: Is it good or bad? Nature decides when and where IS Pateras, S Havaki, X Nikitopoulou, K Vougas, PA Townsend, ... Pharmacology & therapeutics 154, 36-56, 2015 | 150 | 2015 |
| The proteome profile of the human osteosarcoma U2OS cell line KN Niforou, AK Anagnostopoulos, K Vougas, C Kittas, VG Gorgoulis, ... Cancer genomics & proteomics 5 (1), 63-77, 2008 | 136 | 2008 |
| Systemic mechanisms and effects of ionizing radiation: A new⿿ old⿿ paradigm of how the bystanders and distant can become the players Z Nikitaki, IV Mavragani, DA Laskaratou, V Gika, VP Moskvin, ... Seminars in cancer biology 37, 77-95, 2016 | 135 | 2016 |
| Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer G Velimezi, M Liontos, K Vougas, T Roumeliotis, J Bartkova, M Sideridou, ... Nature cell biology 15 (8), 967-977, 2013 | 133 | 2013 |
| Machine learning and data mining frameworks for predicting drug response in cancer: An overview and a novel in silico screening process based on association rule mining K Vougas, T Sakellaropoulos, A Kotsinas, GRP Foukas, A Ntargaras, ... Pharmacology & therapeutics 203, 107395, 2019 | 122 | 2019 |
| Comparative analysis of label-free and 8-Plex iTRAQ approach for quantitative tissue proteomic analysis A Latosinska, K Vougas, M Makridakis, J Klein, W Mullen, M Abbas, ... PloS one 10 (9), e0137048, 2015 | 118 | 2015 |
| Brain proteome response following whole body exposure of mice to mobile phone or wireless DECT base radiation AF Fragopoulou, A Samara, MH Antonelou, A Xanthopoulou, ... Electromagnetic Biology and Medicine 31 (4), 250-274, 2012 | 114 | 2012 |
| Depression, physical activity, energy consumption, and quality of life in OSA patients before and after CPAP treatment C Diamanti, E Manali, M Ginieri-Coccossis, K Vougas, K Cholidou, ... Sleep and breathing 17, 1159-1168, 2013 | 102 | 2013 |
| Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells A Pavlopoulou, Y Oktay, K Vougas, M Louka, CE Vorgias, AG Georgakilas Cancer letters 380 (2), 485-493, 2016 | 92 | 2016 |
| Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma A Kolialexi, GT Tsangaris, N Papantoniou, AK Anagnostopoulos, ... Prenatal diagnosis 28 (8), 691-698, 2008 | 85 | 2008 |
| Characterization of the human urine proteome by preparative electrophoresis in combination with 2‐DE PG Zerefos, K Vougas, P Dimitraki, S Kossida, A Petrolekas, ... Proteomics 6 (15), 4346-4355, 2006 | 74 | 2006 |
| Marked defects in the expression and glycosylation of α2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and … PM Karamessinis, A Malamitsi-Puchner, T Boutsikou, M Makridakis, ... Molecular & Cellular Proteomics 7 (3), 591-599, 2008 | 70 | 2008 |
| Protein biomarkers distinguish between high-and low-risk pediatric acute lymphoblastic leukemia in a tissue specific manner M Braoudaki, GI Lambrou, K Vougas, K Karamolegou, GT Tsangaris, ... Journal of hematology & oncology 6, 1-20, 2013 | 65 | 2013 |
| Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation EN Tsakiri, S Gumeni, KK Iliaki, D Benaki, K Vougas, GP Sykiotis, ... Aging cell 18 (1), e12845, 2019 | 59 | 2019 |
| Comparison of depletion strategies for the enrichment of low-abundance proteins in urine S Filip, K Vougas, J Zoidakis, A Latosinska, W Mullen, G Spasovski, ... PLoS One 10 (7), e0133773, 2015 | 58 | 2015 |
George P. ChrousosProfessor, School of Medicine, National and Kapodistrian University of AthensVerified email at med.uoa.gr